Perrigo Company plc Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate
Perrigo Company plc (PRGO) reported Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate of 2.11% for the 12-month period ending 2015-06-27, per its 10-K filed 2015-08-13.
Discontinued › Expense Statement › Operating Expenses
us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate · last filed 2015-08-13
- Perrigo Company plc defined benefit plan, assumptions used calculating net periodic benefit cost, discount rate for fiscal 2015 was 2.11%, a 27.24% decline from fiscal 2014.
- Perrigo Company plc defined benefit plan, assumptions used calculating net periodic benefit cost, discount rate for fiscal 2014 was 2.90%.
| Period end | Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate 6 month | Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate 12 month |
|---|---|---|
| 2015-06-27 | 2.11% 10-K · filed 2015-08-13 | |
| 2014-06-28 | 2.90% 10-K · filed 2014-08-14 | 2.90% 10-K · filed 2015-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |